Furthermore, rhamnetin and cirsiliol have been demonstrated to display anticancer effects and the ability to sensitize radioresistant cells through the inhibition of EMT markers, including fibronectin, vimentin, and E-cadherin, in non-small cell lung cancer cells [50]. This evidence concerns the gene FN1 and non-small cell lung carcinoma.